Phenacetin 非那西丁
CAS 62-44-2 MFCD00009094
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} Analytical Standards,
- {SNA} Bioactive Small Molecules, Building Blocks, Cell Biology, Chemical Synthesis,
- {SNA} Analytic
- {SNA} Analytical Standards, Analytical/Chromatography, Chromatography, Pharmaceutical Secondary Standards, Pharmaceutical Standards
- {SA} Bioactive Small Molecules, Building Blocks, Cell Biology, Chemical Synthesis, Nitrogen Compounds, Organic Building Blocks, P, Protected Amines
- {SNA} Bioactive Small Molecules, Building Blocks, Chemical Synthesis, Nitrogen Compounds, Organic Building Blocks, P, Protected Amines, 细胞生物学
- Pharmaceuticals
- {SNA} Building Blocks, Chemical Synthesis,
产品应用
- CYP1A2 和 CYP2D6 的底物。
相关文献及参考
- Short: III/35E
- Boyd, et al.: Toxicol. Appl. Pharmacol., 1, 240 (1959),
- Short: IV/1a
- Short: IV/20B
- Merck: 14,7204 Beilstein:13(4)1092
- Dubach, C.U., et al.: N. Engl. J. Med., 308, 357 (1983),
- Merck: 14,7204
安全信息
GHS Symbol
- P308+P313
- P201 Obtain special instructions before use. 使用前获取专门指示。
- P264 Wash hands thoroughly after handling. 处理后要彻底洗净双手。
- P501 Dispose of contents/container to..… 处理内容物/容器.....
- P405 Store locked up. 上锁保管。
- P263 Avoid contact during pregnancy/while nursing. 怀孕/哺乳期间避免接触。
- P281 Use personal protective equipment as required. 使用所需的个人防护装备。
- P260 Do not breathe dust/fume/gas/mist/vapours/spray. 不要吸入粉尘/烟/气体/烟雾/蒸汽/喷雾。
- P202 Do not handle until all safety precautions have been read and understood. 已阅读并理解所有的安全预防措施之前,切勿操作。
- H350 May cause cancer 可能致癌
- H302 Harmful if swallowed 吞食有害
- S45 In case of accident or if you feel unwell seek medical advice immediately (show the label where possible) 发生事故时或感觉不适时,立即求医(可能时出示标签);
- S53 Avoid exposure - obtain special instructions before use 避免接触,使用前获得特别指示说明;
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 1008 gm/kg/96W-C TOXIC EFFECTS : Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - tumors Kidney, Ureter, Bladder - Kidney tumors REFERENCE : IJCNAW International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- Volume(issue)/page/year: 29,439,1982
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 572 gm/kg/60W-C TOXIC EFFECTS : Tumorigenic - Carcinogenic by RTECS criteria Sense Organs and Special Senses (Olfaction) - tumors Kidney, Ureter, Bladder - tumors REFERENCE : GANNA2 Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. Volume(issue)/page/year: 70,29,1979
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Human DOSE/DURATION : 7300 mg/kg/Y-C TOXIC EFFECTS : Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - Kidney tumors REFERENCE : SJUNAS Scandinavian Journal of Urology and Nephrology. (Almqvist & Wiksell, POB 45150, S-10430 Stockholm, Sweden) V.1- 1967- Volume(issue)/page/year: 2,145,1968
TYPE OF TEST : TD - Toxic dose (other than lowest) ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Human - woman DOSE/DURATION : 140 gm/kg/13Y-I TOXIC EFFECTS : Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - Kidney tumors REFERENCE : BJURAN British Journal of Urology. (Longman Group Ltd., POB 11318, Birmingham, AL 35202) V.1- 1929- Volum
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - rabbit DOSE/DURATION : 1 gm/kg TOXIC EFFECTS : Behavioral - convulsions or effect on seizure threshold REFERENCE : ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 21,719,1971
TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Unreported SPECIES OBSERVED : Human - man DOSE/DURATION : 74 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : 85DCAI "Poisoning; Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970 Volume(issue)/page/year: 2,73,1970
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERV
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 1625 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 8,25,1958
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - hamster DOSE/DURATION : 1690 mg/kg TOXIC EFFECTS : Behavioral - ataxia Behavioral - coma Cardiac - pulse rate increase, without fall in BP REFERENCE : PHARAT Pharmazie. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1946- Volume(issue)/page/year: 8,572,1953
TYPE OF TEST : Cytogenetic analysis ROUTE OF EXPOSURE : Oral TEST SYSTEM : Rodent - rat DOSE/DURATION : 263 gm/kg/17W (Continuous) REFERENCE : MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 79,13,1980
{h
TYPE OF TEST : Mutation in microorganisms TEST SYSTEM : Bacteria - Salmonella typhimurium DOSE/DURATION : 333 ug/plate REFERENCE : IAPUDO IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- Volume(issue)/page/year: 27,283,1980
TYPE OF TEST : DNA inhibition ROUTE OF EXPOSURE : Intraperitoneal TEST SYSTEM : Rodent - mouse DOSE/DURATION : 20 gm/kg REFERENCE : ARGEAR Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1949- Volume(issue)/page/year: 51,605,1981
TYPE OF TEST : DNA damage ROUTE OF EXPOSURE : Intraperitoneal TEST SYSTEM : Rodent - mouse DOSE/DURATION : 400 mg/kg REFERENCE : ATSUDG Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- Volume(issue)/page/year: 5,355,1982
TYPE OF TEST : Host-mediated assay TEST SYSTEM : Rodent - rat Bacteria - Salmonella typhimurium DOSE/DURATION : 200 ug/kg REFERENCE : ONCODU Revista de Chirurgui, Oncologie, Radiologie, ORL, Oftalmologie, Stomatologie, Seria: Oncologia. (Rompresfilatelia, POB 12-201, Bucharest, Romania) V.13(4)- 1974- Volume(issue)/page/year: 19,183,1980
TYPE OF TEST : DNA damage ROUTE OF EXPOSURE : Intraperitoneal TEST SYSTEM : Rodent - rat DOSE/DU
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE : 57200 mg/kg SEX/DURATION : male 20 week(s) pre-mating TOXIC EFFECTS : Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count) REFERENCE : JCNDBK Journal of Clinical Pharmacology and New Drugs. (Stamford, CT) V.11-13, 1971-73. For publisher information, see JCPCBR. Volume(issue)/page/year: 11,96,1971
TYPE OF TEST : TDL
{hazar
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE : 50336 mg/kg SEX/DURATION : male 17 week(s) pre-mating TOXIC EFFECTS : Reproductive - Fertility - male fertility index (e.g. # males impregnating females per # males exposed to fertile nonpregnant females) REFERENCE : JCNDBK Journal of Clinical Pharmacology and New Drugs. (Stamford, CT) V.11-13, 1971-73. For publisher information, see JCPCBR. Volume(issue)/page/year: 11,96,1971
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE : 6 gm/kg SEX/DURATION : female 1-20 day(s) after conception TOXIC EFFECTS : Reproductive - Specific Developmental Abnormalities - musculoskeletal system REFERENCE : KLWOAZ Klinische Wochenscrift. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1922- Volume(issue)/page/year: 43,364,1965
其他信息
- 用途二:对乙酰氨基苯乙醚用作有机合成原料及药物中间体。
- Acros Org
- 下游产品:
- 图谱信息:非那西丁(62-44-2)红外图谱(IR1) 非那西丁(62-44-2)Raman光谱 非那西丁(62-44-2)核磁图( 13 CNMR) 非那西丁(62-44-2)红外图谱(IR2) 非那西丁(62-44-2)质谱(MS)
- 本品为白色,无臭,味微苦。本品在乙醇或氯仿中溶解,在沸水中略溶,微溶于甘油。溶解度:1g/1310ml冷水、1g/82ml 、1g/15ml 冷乙醇、1g/2.8ml 沸乙醇、1g/14ml 氯仿、1g/90ml 醚。
- 可燃性危险特性:明火可燃;加热分解释放有毒氮氧化物气体;该药副作用:苍白,肝受损,血红蛋白症
- TCI Shanghai:对乙酰氨基苯乙醚 Phenacetin,>;98.0%(GC)(62-44-2)
- Sigma Aldrich:62-44-2(sigmaaldrich)
- 副作用:长期服用含非那西丁的制剂,可引起肾乳头坏死、间质性肾炎等,甚至可能诱发肾盂癌和膀胱癌。非那西丁还易使血红蛋白形成高铁血红蛋白,使血液携氧能力下降,引起紫绀反应。此外,非那西丁还可引起溶血和溶血性贫血,并对视网膜有一定毒性。长期服用非那西丁,还可造成对药物的依赖性。国外如美、英、德、日本等国家都决定取消非那西丁,或规定在其包装上须注明“不能长期服用或大剂量服用”。
- 解热镇痛药:非那西丁的解热镇痛作用与“乙酰水杨酸”相似,主要用作解热镇痛药,作用缓慢而持久,对治疗头痛、神经痛、关节痛和发热等都有较好疗效,但抗风湿、消炎作用较弱。剂量过大可导致高铁血红蛋白症,造成机体缺氧,长期用药可损害肾脏,甚至引起乳头坏死,应慎用。因其毒副作用和其他同类药物的迅速发展,该药已停止单独使用,只是作为原料药和其他药物配复方制剂。常与阿司匹林、咖啡因一起组成复方阿司匹林,其组成为非那西丁0.162克,阿司匹林 0.227克,咖啡因0.035克,毒性较小,用于治疗伤风感冒。如在上述药物中加入少量扑尔敏,还可制成扑尔敏感冒片,可用于治疗感冒头痛、神经痛、风湿痛等。 非那西丁本身并无解热镇痛作用,在机体内,经过代谢分解出对乙酰氨基酚即扑热息痛,才发挥出解热镇痛的效果。还分解出对氨苯乙醚,对氨苯乙醚不但无解热镇痛作用,且是非那西丁毒副作用的主要因素。 中国于1954年开始生产非那西丁,由硝基氯苯与乙醇进行醚化反应得对硝基苯乙醚,再还原成对氨基苯乙醚后与乙酸进行乙酰化反应制得。
- MOL 文件:62-44-2.mol
- 方法一:(1)由对氨基苯乙醚经乙酰化而得。将苯、乙酐和对氨基苯乙醚的混合物,在油浴上加热共沸4h,反应完毕后冷却反应物,即析出非那汀,经过滤,冷苯洗涤,干燥即得,产量为理论量的86%。(2)由乙酰氨基苯酚与乙醇钠作用而得:先将对乙酰胺基苯酚加于乙醇钠中,再缓缓加入碘乙烷,加热回流1h,冷却,过滤,所得粗品溶于乙醇中,过滤,滤液用热水稀释,再经冷却,过滤,干燥,而得成品,产量为理论量的80%。第一个方法也可不用苯作溶剂,而用乙酸代替,工艺过程如下。将40%的稀乙酸加热至沸,投入对氨基苯乙醚,蒸去水,待温度升到150℃时加入冰醋酸,回流1h,继续蒸,待温度升至150℃以上,取样测定游离氨基苯乙醚,根据残余的氨基苯乙醚量加入乙酐,回流反应0.5h,检查终点,合格后减压,回收乙酸至氨基含量在0.046以下,含酸0.2%以下,将反应液压入热精制母液中,搅拌降温至40℃,过滤,得非那西汀粗品。精制,非那西汀粗品加沸水或精制母液,加热搅拌溶解,过滤,滤液用酸调节至pH=4.5-4.7,加入活性炭及硫代硫酸钠搅拌脱色,过滤,滤液冷却结晶,甩滤,气流干燥,得非那西汀。
- 非那西丁价格(试剂级):更新日期 产品编号 产品名称 包装 价格 2011/08/23 K7744001 菲那西汀 50g 239元 2011/04/16 P1669 非那西丁 Phenacetin 25G 11
- 毒性分级:中毒
- 用途一:解热镇痛药,用于治疗发热头痛、神经痛等
- MSDS 信息:乙酰乙氧基苯胺(62-44-2).msds
- 急性毒性:口服-大鼠 LD50: